Construction and Validation of the Modified Parietal Atrophy Index by Magnetic Resonance Imaging in Patients With Alzheimer's Disease in a Memory Clinic
European Journal of Neuroscience · 2025
DOI: 10.1111/ejn.70095 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift European Journal of Neuroscience, 2025. Verfasst von Alberto José Mimenza-Alvarado und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, INCMNSZ, Mexico City, Mexico. Hauptthemen laut MEDLINE: Alzheimer Disease, Magnetic Resonance Imaging, Parietal Lobe. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Magnetic resonance imaging (MRI) is pivotal to the evaluation of cerebral atrophy in Alzheimer's disease ( AD ). Although there are several scoring systems to identify atrophy in areas of interest, the possibility of having a simple and practical scale focused on evaluating parietal atrophy by MRI in a single axial slice in T2‐Flair sequencing would be highly advantageous. We develop and validate the Mimenza–Aguilar–Herrera (MAH) visual scale to determine the degree of modified parietal atrophy by analyzing the posterior cingulate gyrus in an MRI axial slice in T2 weighted sequencing in individuals with early AD . Patients with AD , mild cognitive impairment, and other dementias were included. Interrater and intrarater concordance was analyzed with Cohen's kappa. ROC analysis was used to determine sensitivity/specificity. The relationship between medial parietal atrophy (MPA) and the MMSE and MoCA scores, age, educational level, and sex was determined by linear regression. Interrater concordance in the MPA‐MAH was moderate, 0.83 ( p = 0.001). The area under the curve in the mild AD group was 0.74, with a sensitivity of 71.67% and a specificity of 76.19% ( p < 0.001). An association was detected between a MPA score > 1 [OR 5.1 (95% CI: 2–12.9, p < 0.001)], MMSE < 24 pts, [OR 4.5 (95% CI: 1.2–17.6, p = 0.026)], and MoCA < 24 pts, after adjusting for age and sex. The MAH scale proved useful in diagnosing early AD , with comparable performance to validated scales such as Koedam's and Scheltens'. This instrument could allow a quick and easy evaluation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Geriatrics, INCMNSZ, Mexico City, Mexico.
- Fellow in Neurological-Geriatrics, INCMNSZ, Mexico City, Mexico.
- Department of Radiology, INCMNSZ, Mexico City, Mexico.
- Centro de Investigación sobre el Envejecimiento-CINVESTAV sede sur, México City, Mexico.
ORCID-Profile: Juan de Dios Rodríguez-Callejas
Zitieren
APA
Mimenza-Alvarado, A. J., Herrera-Martínez, D. A., Rubalcava-Ortega, J., González-Putoy, M. Y., Rodríguez-Callejas, J. D., & Aguilar-Navarro, S. G. (2025). Construction and Validation of the Modified Parietal Atrophy Index by Magnetic Resonance Imaging in Patients With Alzheimer's Disease in a Memory Clinic. European Journal of Neuroscience. https://doi.org/10.1111/ejn.70095
Vancouver
Mimenza-Alvarado AJ, Herrera-Martínez DA, Rubalcava-Ortega J, González-Putoy MY, Rodríguez-Callejas JD, Aguilar-Navarro SG. Construction and Validation of the Modified Parietal Atrophy Index by Magnetic Resonance Imaging in Patients With Alzheimer's Disease in a Memory Clinic. European Journal of Neuroscience. 2025. doi:10.1111/ejn.70095
BibTeX
@article{MimenzaAlvarado2025,
author = {Mimenza-Alvarado, Alberto José and Herrera-Martínez, Daniel Alberto and Rubalcava-Ortega, Johnatan and González-Putoy, Michelle Yanieska and Rodríguez-Callejas, Juan de Dios and Aguilar-Navarro, Sara Gloria},
title = {Construction and Validation of the Modified Parietal Atrophy Index by Magnetic Resonance Imaging in Patients With Alzheimer's Disease in a Memory Clinic},
journal = {European Journal of Neuroscience},
year = {2025},
doi = {10.1111/ejn.70095}
}
EUVIMED